Macy’s Guidance Reset Exposes the Hidden Risk in the Stock’s "Cheap" Valuation

The market's verdict was clear: the headline beat was already priced in, leaving the guidance reset to drive the real move. Macy's delivered a solid fourth-quarter report, but the stock fell 6.01% to $12.51 in pre-market trading. This classic "sell the news" reaction highlights the core expectation gap. The company posted EPS of $1.80, a significant 16.9% beat against the consensus forecast of $1.54. Yet, revenue of $7.77 billion narrowly missed the $7.78 billion target. The whisper number for earnings was met, but the forward view was what mattered.

The focus shifted immediately to the outlook. Management's guidance for 2025 painted a cautious picture, with net sales expected between $21.0 and $21.4 billion and adjusted EPS in a range of $2.05 to $2.25. More telling was the forecast for comparable sales to decline by 0.5% to 2%. In a retail environment already under pressure, this guided contraction was the critical data point. The market's reaction confirms that for all the satisfaction with the quarterly beat, the forward trajectory was the dealbreaker. The stock's decline signals that investors were looking past the past quarter's results and focusing squarely on the challenging path ahead.

The Guidance Reset: What Was Priced In?

The market's verdict was a reset, not a surprise. Macy's guidance for the fourth quarter was the critical data point that shattered the momentum priced into the stock. Management guided for net sales to fall 3%-5% from a year ago to a range of $7.35 billion-$7.5 billion. This forecast of contraction followed a period of strong performance, including a third-quarter beat-and-raise where same-store sales grew 2.5% and the stock popped nearly 2%. The expectation gap here is stark. After three straight quarters of beating the Street and two of comp growth, the market had likely priced in continued momentum. The guidance, instead, signaled a sharp reversal.

The headwinds cited were not fully discounted. Management pointed to selective spending among its consumers and higher tariffs as key pressures. These are real frictions, but they were not the dominant narrative in the stock's recent run. The guidance reset forced a reality check. It told investors that the recent operational wins were not a permanent trend, but a pause before a more challenging period. This is the essence of an expectation gap: the forward view was the dealbreaker.

The bottom line is that the stock's decline reflects a guidance reset, not a fundamental breakdown. The company's cautious outlook followed a period of strong comps and beat-and-raises, meaning the market had likely priced in continued momentum. The guidance, with its forecast for a sales decline, was the critical data point that shattered that priced-in optimism.

Valuation Context and Financial Health

The stock's cheap valuation now faces a tough test. Macy's trades at a trailing P/E of 10.09, a multiple that suggests the market sees it as undervalued. Analysts project a 6.5% annual earnings growth rate, which, combined with the current price, implies a path to fair value. Yet the guidance reset complicates this thesis. The market had likely priced in continued operational momentum from the prior quarters. The new outlook, with a forecast for a 3%-5% sales decline, forces a reassessment. The stock's recent slide to near its 52-week low of $9.76 highlights the market's skepticism about the near-term inflection point. The valuation discount is now a bet on a turnaround that guidance says is still months away.

A key risk is the company's financial structure. While the earnings beat was solid, it was likely aided by one-off items and cost cuts. The sustainability of that profit growth is in question. More broadly, the company's high debt load is a persistent pressure point that can constrain future earnings growth, especially if interest rates remain elevated. This creates a tension: the stock is cheap, but the path to earnings expansion is clouded by these structural frictions and the guided contraction in sales.

The bottom line is that the guidance reset has shifted the investment case. The low P/E and high dividend yield of 4.25% remain attractive for long-term holders, but they are now a defensive bet. The market's reaction confirms that for all the satisfaction with the quarterly beat, the forward trajectory was the dealbreaker. The stock's decline signals that investors were looking past the past quarter's results and focusing squarely on the challenging path ahead.

Catalysts and What to Watch

The market's pessimistic view now hinges on a few key catalysts. The primary near-term test is the actual fourth-quarter sales figure, which must be measured against the guided range of $7.35 billion to $7.5 billion. A result at the low end of that range, or worse, would confirm the guided contraction and likely sustain the stock's downward pressure. Conversely, a figure closer to the high end could signal that the cautious outlook was overly conservative, potentially sparking a relief rally.

Investors should also monitor for any shift in the company's tone on the headwinds cited. Management has pointed to selective spending among its consumers and higher tariffs as key pressures. If the earnings call reveals signs that these frictions are easing or if the company expresses more confidence in its ability to navigate them, it could begin to reset the narrative. Any change in language around the "K-shaped economy" or the performance of its luxury Bloomingdale's segment would be a critical signal.

Finally, the stock's reaction to the earnings call and any subsequent guidance updates for fiscal 2026 will be critical for momentum. The company's leadership has been cautious, stating they don't want to get ahead of their skis after recent beats. However, if the call provides more clarity on the path to growth or hints at a potential acceleration in the second half of the year, it could start to rebuild credibility. The bottom line is that the current setup is one of expectation arbitrage: the stock's cheap valuation is a bet on a turnaround that guidance says is still months away. The coming weeks will determine if that bet is justified.